The role of ceramide in the cellular response to cytotoxic agents

Current Opinion in Oncology

Volumn 10, Issue 6, 1998, Pages 552-559

  Jarvis, W David ^a   Grant, Steven ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CERAMIDE; CYTARABINE; CYTOTOXIC AGENT; DAUNORUBICIN; SPHINGOLIPID;

APOPTOSIS; CELL DEATH; CHEMOTHERAPY; GENOTOXICITY; HUMAN; HUMAN CELL; IONIZING RADIATION; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS;

EID: 0031756497     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199811000-00013     Document Type: Review

References (108)

1. Kolesnick RN: Regulation of ceramide production and apoptosis. Annu Rev Physiol 1998, 60:643-668.
2. Ariga T, Jarvis WD, Yu RK: The role of sphingolipid-mediated cell death in neurodegenerative disease. J Lipid Res 1998, 39:1-16.
3. Pyne S, Tolan DG, Conway AM, Pyne N: Sphingolipids as differential regulators of cellular signalling processes. Biochem Soc Trans 1997, 25:549-556.
4. Smyth MJ, Obeid L, Hannun YA: Ceramide: a novel mediator of apoptosis. Adv Pharmacol 1997, 41:133-154.
5. Brindley DN, Abousalham A, Kikuchi Y, Wang CN, Waggoner DW: Crosstalk between bioactive glycerolipids and sphingolipids in signal transduction. Biochem Cell Biol 1996, 74:469-476.
6. Jarvis WD, Grant S, and Kolesnick RN: Ceramide and the induction of apoptosis. Clin Cancer Res 1996, 2:1-6.
7. Merrill AH, Hannun YA, Bell RM: Sphingolipids and their metabolites in cell regulation. Adv Lipid Res 1993, 23:1-26.
8. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Kolesnick RN: Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995, 82:405-414. The initial report implicating the ceramide synthase pathway in drug-induced cell death.
9. Jaffrezou J-P, Levade T, Bettaib A, Andrieu N, Bezombes C, Maestre N, Vermeersch S, Rousse A, Laurent G: Daunorubicin-induced apoptosis: triggering ceramide generation through sphingomyelin hydrolysis. EMBO J 1996, 15:2417-2424.
10. Mansat V, Laurent G, Levade T, Bettaib A, Jaffrezou J-P: The protein kinase C activators phorbol diesters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res 1997, 57:5300-5304.
11. Joseph CK, Byun HS, Bittman R, Kolesnick RN: Substrate recognition by ceramide-activated protein kinase: evidence that kinase activity is proline-directed. J Biol Chem 1993, 268:20002-20006.
12. Liu J, Mathias S, Yang Z, Kolesnick RN: Renaturation and TNFα stimulation of a 97-KDa ceramide-activated protein kinase. J Biol Chem 1994, 269:3047-3052.
13. Mathias S, Younes A, Kan C-C, Orlow I, Joseph C, and Kolesnick RN: Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 1993, 259:519-522.
14. Zhang Y, Yao B, Delikat S, Bayoumy S, Lin X-H, Basu S, et al.: Kinase suppressor of ras is ceramide-activated protein kinase. Cell 89:63-72, 1997.
15. Dobrowsky RT, Hannun YA: Ceramide stimulates a cytosolic protein phosphatase. J Biol Chem 1992, 267:5048-5051.
16. Dobrowsky RT, Kamibayishi C, Mumby MC, Hannun YA: Ceramide activates a heterotrimeric protein phosphatase A2. J Biol Chem 1993, 268:15523-15530.
17. Wolff RA, Dobrowsky TR, Bielawska A, Hannun YA: Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem 1994, 269:19605-19609.
18. Huwiler A, Brunner J, Hummel R, Vervooddeldonk M, Dtabels S, van den Bosch H, Pfeilshifter J: Ceramide-binding and activation defines c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci U S A 1996, 93:6959-6965.
19. Lozano J, Berra E, Municio MM, Diaz-Meco MF, Dominguez I, Sanz L, Moscat J: Protein kinase C-ζ is critical for NF-κB-dependent promoter activation by sphingomyelinase. J Biol Chem 1994, 269:19200-19202.
20. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro P, Pfizenmaier K: Protein kinase C-ζ is a molecular switch in signal transduction of TNFα, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995, 14:1961-1969.
21. Gulbins E, Coggeshall M, Baier G, Telford D, Langtet C, Baier-Bitterlich G, et al.: Direct stimulation of vav guanine nucleotide exchange activity for ras by phorbol diesters and diglyceride. Mol Cell Biol 1994, 14:4749-4758.
22. Westwick JK, Bielawska ARE, Dbaibo GS, Hannun YA, Brenner DA: Ceramide activates the stress-activated protein kinases. J Biol Chem 1995, 270:22689-22692.
23. Verheij M, Bose R, Lin X-H, Yao B, Jarvis WD, Grant S, et al.: Requirement for ceramide-initiated stress-activated protein kinase/c-Jun aminoterminal kinase (SAPK/JNK) signalling in stress-induced apoptosis. Nature 1996, 380:75-79. This study demonstrates the essential involvement of SAPK-AP1 signaling in the cytotoxicity of ceramide and ceramide-dependent lethal stimuli.
24. Sawai H, Okazaki T, Yamamoto H, Okano H, Takeda Y, Tashima M. et al.: Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem 1995, 270:27326-27331.
25. Jarvis WD, Fornari FA, Auer KL, Freemerman AJ, Szabo E, Birrer MJ, et al.: Coordinate regulation of stress-activated protein kinase (SAPK) and mitogen-activated protein kinase (MAPK) cascades in the apoptotic actions of ceramide and sphingosine in human myeloid leukemia cells. Mol Pharmacol 1997, 52:935-947.
26. Jarvis WD, Fornari FA, Browning JL, Gewirtz DA, Kolesnick RN, Grant S: Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J Biol Chem 1994, 269:31685-31692.
27. Jarvis WD, Fornari FA, Traylor RS, Martin HA, Kramer LB, Erukulla RK, et al.: Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J Biol Chem 1996, 271:8275-8284.
28. Xia Z, Dickens M, Raingeaud J, David RJ, Greenberg ME. Opposing effects of ERK, JNK, and RK kinases on apoptosis. Science 1995, 270:1326-1331. This paper demonstrates that cell survival is determined by changes in the balance between MAPK and SAPK signaling.
29. Waldman T, Langauer C, Keazler KW, Vogelstein B: Uncoupling of S-phase and mitosis induced by anticancer agents lacking p21. Nature 1996, 381:713-716.
30. Ruan S, Fatih M, Ren J-P, Chiao P, Andreef M, Levin V, Zhang W: Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitroso-urea and cisplatin. Cancer Res 1998, 58:1538-1543.
31. Wang C-Y, Mayo MW, Baldwin AS: TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NFκB. Science 1996, 274:784-787.
32. Cuvillier O, Pirianov L, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996, 381:800-803.
33. Garcia-Ruiz C, Collel A, Mari M, Morales A, Fernandez-Checa JC: Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species: role of mitochondrial glutathione. J Biol Chem 1997, 272:11369-11377.
34. Arora AS, Jones BJ, Patel TC, Bronk SF, Goreo GS: Ceramide induces hepatocyte cell death through disruption of mitochondrial function in the rat. Hepatology 1997, 25:958-963.
35. Hirsch T, Susin SA, Marzo I, Marchetti P, Zamzami N, Kroemer G: Mitochondrial permeability transition in apoptosis and necrosis. Cell Biol Toxicol 1998, 14:141-145.
36. Fuks Z, Haimovitz-Friedman A, Kolesnick RN: The role of the sphingomyelin pathway in radiation-induced cell kill. Important Adv Oncol 1995, 9:19-31.
37. Haimovitz-Friedman A, Kolesnick RN, Fuks Z: Differential inhibition of radiation-induced apoptosis. Stem Cells 1997, 15:43-47.
38. Haimovitz-Friedman A, Kan C, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z, Kolesnick RN: Ionizing radiation acts on cellular membranes in human leukemia cells to generate ceramide and induce apoptosis. J Exp Med 1994, 180:525-535.
39. Chen YR, Meyer CF, Tan TH: Persistent activation of Jun N-terminal kinase (JNK) in γ-irradiation-induced apoptosis. J Biol Chem 1996, 271:631-634.
40. Sherman MI, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW: Ionizing radiation regulates expression of the c-Jun proto-oncogene. Proc Natl Acad Sci U S A 1990, 87:5663-5666.
41. Lee YJ, Galoforo SS, Berns CM, Erdos G, Gupta AK, Ways DK, Lorry PM: Effects of ionizing radiation on AP1-binding activity by drug-sensitive and multidrug-resistant cells. J Biol Chem 1995, 270:28790-28796.
42. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz HL, et al.: Basic fibroblastic growth factor protects endothelial cells from programmed cell death in vitro and in vivo. Cancer Res 1994, 54:2582-2590.
43. Chmura SJ, Nodzenski E, Beckett MA, Kufe DW, Quintans J, Weichselbaum RR: Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res 1997, 57:1270-1275.
44. Chmura SJ, Mauceri HJ, Advani S, Heimann R, Beckett MA, Nodzenski E, et al.: Decreasing the apoptotic threshold of tumor cells through protein kinase C and sphingomyelinase activation increases tumor killing by ionizing radiation. Cancer Res 1997, 57:4340-4347.
45. Michael JM, Lavin MF, Watters DJ: Resistance to radiation-induced apoptosis in Burkitt's lymphoma is associated with defective ceramide signaling. Cancer Res 1997, 57:3600-3605.
46. Bruno AP, Laurent G, Averbeck D, Demur C, Bonnet J, Bettaib A, et al.: Lack of ceramide generation in TF-1 human myeloid leukemia cells resistant to ionizing radiation. Cell Death Differ 1998, 5:173-182.
47. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, et al.: Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996, 86:189-199. This report provides direct evidence of a functional involvement of acidic sphingomyelinase in radiation-related cell death.
48. Richardson DS, Johnson SA: Anthracyclines in hematology: preclinical studies, toxicity, and delivery systems. Blood Rev 1997, 11:201-223.
49. Mansat V, Bettaib A, Levade T, Laurent G, Jaffrezou JP: Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. FASEB J 1997, 11:695-702.
50. Allouche M, Bettaieb A, Vindis C, Rousse A, Gringon C, Laurent G: Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells. Oncogene 1997, 14:1837-1845.
51. Witty JP, Bridgham JT, Johnson AL: Induction of apoptotic cell death in hen granulosa cells by ceramide. Endocrinology 1996, 137:5269-5272.
52. 3 positions. Biochim Biophys Acta 1995, 1256:25-30.
53. Jaffrezou J-P, Levade T, Chatelain P, Laurent G: Modulation of subcellular distribution of doxorubicin in multidrug-resistant p388 leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxyphenyl)amino]propyloxy)- benzenesulfonyl))indolizine. Cancer Res 1992, 52:6440-6446.
54. Amarante-Mendez GP, Finucane DM, Martin SJ, Cotter TG, Salvesan GS, Green DR: Anti-apoptotic oncogenes prevent caspase-dependent and -independent commitment to cell death. Cell Death Differ 1998, 5:298-306.
55. Brunet CL, Gunby RH, Benson RSP, Hickman JA, Watson AJM, Brady C: Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Differ 1998, 5:107-115.
56. Grant S: 1-[β-D-arabinofuranosyl]cytosine: molecular and cellular pharmacology. Adv Cancer Res 1997, 72:197-233.
57. Kucera GL, Capizzi RL: 1-[β-D-arabinofuranosyl]cytosine-diphosphate is formed by reversal of cholinephosphotransferase and not via cytidylyltransferase. Cancer Res 1992, 52:3886-3891. This paper illustrates the first direct evidence of diglyceride formation in response to ara-C, providing a possible mechanism for ara C-induced cPKC/nPKC activation.
58. Strum, JL, Small GW, Pauig SB, Daniel LW: 1-[β-D-arabinofuranosyl]cytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem 1994, 269:15493-15497. This study demonstrates that ara-C-lethality is associated with generation of both ceramide and diglyceride.
59. Kharbanda SM, Datta R, Kufe DW: Regulation of c-jun expression in HL-60 leukemia cells by 1-[β-D-arabinofuranosyl]cytosine; potential involvement of a protein kinase C mechanism. Biochemistry 1991, 30:7747-7752.
60. Wang LM, Kucera GL: Deoxycytidine kinase in phosphorylated in vitro and in vivo by protein kinase C. Biochim Biophys Acta 1994, 1224:161-167.
61. 11 activation by 1-[β-D-arabinofuranosyl]-cytosine is antagonistic to stimulation of apoptosis and Bcl-2 down-regulation. J Biol Chem 1997, 272:23481-23484.
62. Kharbanda SM, Emoto Y, Kiasaki H, Saleem A, Kufe DW: 1-[β-D-arabinofuranosyl]cytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol diester-resistant myeloid leukemia cells. Mol Pharmacol 1994, 46:67-72.
63. Saleem A, Datta R, Yuan Z-M, Kharbanda SM, Kufe DW: Involvement of stress-activated protein kinase in the cellular response to 1-[β-D-arabinofuranosyl]cytosine and other DNA-damaging agents. Cell Growth Differ 1995, 6:1651-1658.
64. Kharbanda SM, Sherman MC, Kufe DW: Transcriptional regulation of c-jun gene expression by 1-[β-D-arabinofuranosyl]cytosine in human myeloid leukemia cells. J Clin Invest 1990, 86:1517-1523.
65. Brach, MA, Herrmann F, Kufe DW: Activation of the AP-1 transcription factor by 1-[β-D-arabinofuranosyl]cytosine in myeloid leukemia cells. Blood 1992, 79:728-734.
66. Chen M, Quintans J, Fuks Z, Thompson Z, Kufe DW, Weichselbaum RR: Suppression of bcl2 mRNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor-α, and ceramide. Cancer Res 1995, 55:991-994.
67. Martin SJ, Takahama S, McGahon AJ, Miyashita T, Corbeil J, Kolesnick RN, et al.: Inhibition of ceramide-induced apoptosis by BCL-2. Cell Death Differ 1995, 2:243-252.
68. Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, et al.: Effect of 1-[β-D-arabinofuranosyl]cytosine on apoptosis and differentiation n human monoblastic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM-67). Cell Growth Differ 1996, 7:603-613.
69. Bielawska A, Linardic CM, Hannun YA: Modulation of cell growth and differentiation by ceramide. FEBS Lett 1992, 307:211-214.
70. Zhang J, Alter N, Reed JC, Borner C, Obeid LM, Hannun YA: BCL-2 interrupts the ceramide-mediate pathway of cell death. Proc Natl Acad Sci U S A 1996, 93:5325-5328.
71. 2+-independent sphingomyelinase activities precede commitment to apoptosis and are not a consequence of caspase-3-like activity in Molt-4 cells in response to the thymidylate synthase inhibitor GW1843. Blood 1998, 91:4350-4360.
72. Separovic D, He J, Oleinick NL: Ceramide generation in response to photodynamic treatment of L5178Y mouse lymphoma cells. Cancer Res 1997, 57:1717-1721.
73. Gill JS, Windebank AJ: Role of ceramide in suramin-induced cancer cell death. Cancer Lett 1997, 119:169-176.
74. Suzuki A, Iwasaki M, Kato M, Wagai N: Sequential operation of ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling. Exp Cell Res 1997, 233:41-47.
75. Kolesnick RN, Haimovitz-Friedman A, Fuks Z: The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem Cell Biol 1994, 72:471-474.
76. Gill BM, Nishikata H, Chan G, Delovitch TL, Ochi A: Fas antigen and sphingomyelin/ceramide turnover-mediated signaling: role in life and death of lymphocytes. Immunol Rev 1994, 142:113-125.
77. Tepper CG, Jayadev S, Liu B, Bielawska A, Wolff R, Yonehara S, et al.: Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci U S A 1995, 92:8443-8447.
78. Foghi A, Ravandi A, Teerds KJ, van der Donk H, Kuksis A, Dorrington J: Fas-induced apoptosis signals through sphingomyelin-ceramide pathway. Endocrinology 1998, 139:2041-2047.
79. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, et al.: Apoptotic signaling through (CD95) Fas/APO1 activates an acidic sphingomyelinase. J Exp Med 1994, 180:1547-1552.
80. Cifone MG, Roncaioli P, De Maria R, Camarda G, Santoni A, Ruberti G, Testi R: Multiple pathways originate at the Fas/APO1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J 1995, 14:5859-5868.
81. Di Marzio L, Alesse F, Roncaioli P, Muzi P, Moretti S, Marcellini S, et al.: Influence of I-carnitine on CD95 crosslinking-induced apoptosis and ceramide generation in human cell lines: correlation with effects on purified acidic and neutral sphingomyelinases in vitro. Proc Assoc Am Physicians 1997, 109:154-163.
82. De Maria R, Rippo MR, Schuchman EH, Testi R: Acidic sphingomyelinase is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J Exp Med 1998, 187:897-902.
83. Wright SC, Zhend H, Zhong J: Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24-kDa apoptotic protease AP24. FASEB J 1996, 10:325-332.
84. Adam-Klages S, Schwander R, Adam D, Kreder D, Bernado K, Kronke M: Distinct adaptor proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J Leukoc Biol 1998, 63:678-682.
85. Adam-Klages S, Adam D, Weigmann K, Strubve S, Kolanus W, Schneider-Mergener J, Kronke M: FAN, a novel WD-repeat protein, couples the p55 TNF receptor to neutral sphingomyelinase. Cell 1996, 86:937-947.
86. Gulbins E, Bissonette R, Mahboubi A, Martin S, Nishioka W, Brunner T, et al.: Fas-induced apoptosis is mediated via a ceramide-initiated ras signaling pathway. Immunity 1995, 2:341-351.
87. Gulbins E, Coggeshall KM, Brenner B, Schlottman K, Linderkamp O, Lang F: Fas-induced apoptosis is mediated by activation of a ras and rac protein-regulated signaling pathway. J Biol Chem 1996, 271:26389-26394.
88. Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Land F, Gulbins E: Fas-or ceramide-induced apoptosis is mediated by rac1-regulated activation of Jun N-terminal kinase/p38 kinases and CADD153. J Biol Chem 1997, 272:22173-22181.
89. Roquet N, Carlier K, Briand P, Wiels J, Joulin V: Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes. Biochem Biophys Res Commun 1996, 229:27-35.
90. Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, et al.: The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO1/CD95- and ceramide-induced apoptosis. J Exp Med 1997, 186:25-37.
91. Tepper AD, Cock JG, de Vries E, Borst J, van Blitterswijk WJ: CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32β inhibition. J Biol Chem 1997, 272:24308-24312.
92. Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J: CD95 (Fas/APO1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J Biol Chem 1988, 273:7560-7565.
93. Sillence DJ, Allan D: Evidence against an early signaling role for ceramide in Fas-mediated apoptosis. Biochem J 1997, 324:29-32.
94. Watts JD, Gu M, Polverino AJ, Patterson SD, Aebersold R: Fas-induced apoptosis of T-cells occurs independently of ceramide generation. Proc Natl Acad Sci U S A 1997, 94:7272-7296.
95. Hsu S-C, Wu C-C, Luh T-Y, Chou C-K, Han S-H, Lai M-Z: Apoptotic signal of Fas is not mediated by ceramide. Blood 1998, 91:2658-2663.
96. Latinis KM, Koretzky GA: Fas ligation induces apoptosis and Jnu kinase activation independently of CD45 and Lck in human T cells. Blood 1996, 87:781-875.
97. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81:505-512.
98. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, et al.: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO1) death-inducing signaling complex. Cell 1996, 85:817-827.
99. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME: FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997, 16:2794-2804.
100. Chauhan D, Pandey P, Ogata A, Teoh G, Krett N, Halgren R, et al.: Cytochrome c-dependent and -independent induction of apoptosis of apoptosis in multiple myeloma cells. J Biol Chem 1997, 272:29995-29997.
101. Gamen S, Marzo I, Anel A, Pineiro A, Naval J: CPP-32β inhibition prevents Fas-induced ceramide generation and apoptosis in human cells. FEBS Lett 1996, 390:232-237.
102. Genestier L, Prigent AF, Paillot R, Quemeneur L, Durand J, Banchereau J, et al.: Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis. J Biol Chem 1998, 273:5060-5066.
103. Friesen C, Herr I, Krammer PH, Debatin KM: Involvement of the CD95 (APO-1/Fas) receptor ligand system in drug-induced apoptosis in leukemia cells. Nature Med 1996, 2:574-577.
104. Friesen C, Fulda S, Debatin K-M: Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia 1997, 11:1833-1841.
105. Landowski TH, Geason-Guzman MC, Dalton WS: Selection of drug-resistance results in resistance to Fas-mediated apoptosis. Blood 1997, 89:1854-1861.
106. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil, R: Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res 1997, 57:3331-3334.
107. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, et al.: Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 1997, 90:935-943.
108. Herr I, Wilhelm D, Bohler T, Angel P, Debatin K-M: Activation of CD95 (APO1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J 1997, 16:6200-6208. This study proposes the participation of FasR/FasL in cell-killing by antineoplastic agents.